Back to discover
Disease

Hepatitis, Alcoholic

Clinical development underwayEmerging research
1
Publications
3
Clinical trials
2020
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Clinical trials

2 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
3
All trials
0
Active
0
Late-stage
1
Completed

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Leading journals1
  • Hepatology (Baltimore, Md.)1
Leading researchers5
  • Crabb DW1
  • Im GY1
  • Lucey MR1
  • Mellinger JL1
  • Szabo G1
Affiliations (unnormalised)5
  • Icahn School of Medicine at Mount Sinai1
  • Indiana University School of Medicine1
  • University of Massachusetts Medical School1
  • University of Michigan Hospitals & Health Centers1
  • University of Wisconsin School of Medicine1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

INFLAMMATION of the LIVER due to ALCOHOL ABUSE. It is characterized by NECROSIS of HEPATOCYTES, infiltration by NEUTROPHILS, and deposit of MALLORY BODIES. Depending on its severity, the inflammatory lesion may be reversible or progress to LIVER CIRRHOSIS.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.